Martin Scott, GSK, joins speaker panel for “off-target” webinar


We are delighted to announce that we have extended the line up for our upcoming webinar focusing on specificity screening of biotherapeutics. Dr Martin Scott from GlaxoSmithKline will now be joining us and providing a pharma industry perspective on off-target screening.

Finalised agenda:

“Cell Microarray technology in specificity screening”
Nick Brown, MSc – Retrogenix Limited

“True specificity is a critical development characteristic in therapeutic antibody development”
Jonny Finlay, PhD – CEO, UltraHuman Limited

“Off-target Screening: A Pharma Industry Perspective”
Martin Scott, PhD – Scientific Leader and Associate Fellow, GSK

The webinar is being hosted by Cambridge Innovation Institute. Full details of the program, biographies of the speakers and links to register can be found here